Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Neoadjuvant Chemotherapy Combined With PD-1 Antibody + Radical Radiotherapy in Unresectable Locally Advanced Cervical Cancer Patients

NCT05554276 is registered in ClinicalTrials.gov with Shanghai Jiao Tong University Affiliated Sixth People's Hospital as lead sponsor.

NCT NCT05554276
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05554276 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Neoadjuvant Chemotherapy Combined With PD-1 Antibody + Radical Radiotherapy in Unresectable Locally Advanced Cervical Cancer Patients
Lead sponsor
Shanghai Jiao Tong University Affiliated Sixth People's Hospital
Phase
Phase 2
Overall status
Unknown status
Start date
August 1, 2023
Completion date
December 31, 2025
Enrollment
36 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cervical cancer, neoadjuvant chemotherapy, pd-1 antibody, radiotherapy